Aralez Pharmaceuticals Inc (ARZ)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Aralez Pharmaceuticals Inc (ARZ)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH2490912D
  • |
  • Pages: 42
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Aralez Pharmaceuticals Inc (Aralez Pharma) focuses on the development and commercialization of therapeutic drugs. The company offers products in the fields of cardiovascular diseases, pain management, dermatology and gastrointestinal, other areas. Its pain management products include Cambia, Vimovo, Fiorinal and Fiorinal C, among others. Aralez Pharma also offers non prescription products for women's health. Aralez Pharma works in collaboration with other companies to distribute its products to customers across various regions that include Europe, the US and Canada. The company has presence in New Jersey, the US and Dublin, Ireland. Aralez Pharma is headquartered in Mississauga, Ontario, Canada.

Aralez Pharmaceuticals Inc (ARZ)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Aralez Pharma Acquires US Rights to Toprol-XL and Authorized Generic from AstraZeneca 11

Aralez Pharma Acquires US and Canadian rights to Zontivity from Merck 12

Venture Financing 13

Aralez Pharma Secures USD75 Million in Venture Debt Financing 13

Partnerships 14

Biohit Enters Into Distribution Agreement With Medical Futures 14

Cipher Pharma Enters Into Distribution Agreement With Medical Futures 15

Licensing Agreements 16

Faes Farma Enters into Licensing Agreement with Aralez Pharma 16

Norgine Expands Licensing Agreement With Medical Futures For NORMACOL 16

Apricus Biosciences Enters Into Licensing Agreement with Aralez Pharma 17

Equity Offering 18

Aralez Pharma Raises USD45 Million in Private Placement of Shares 18

Acquisition 19

Tribute Pharma Acquires Medical Futures for USD20 Million 19

Aralez Pharmaceuticals Inc-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Mar 13, 2017: Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results 24

Nov 07, 2016: Aralez Reports Third Quarter 2016 Financial Results 27

Aug 09, 2016: Aralez Reports Second Quarter 2016 Financial Results 29

May 10, 2016: Aralez Reports First Quarter 2016 Financial Results 30

Mar 15, 2016: Aralez Reports Fourth Quarter And Full-Year 2015 Results 32

Corporate Communications 34

Apr 05, 2017: Aralez Announces Reduction In U.S. Sales Force And Cost Savings Program 34

Dec 19, 2016: Aralez Added To The NASDAQ Biotechnology Index 35

Apr 19, 2016: Aralez Appoints James L. Hall As General Manager Of Canadian Business 36

Product News 37

10/03/2016: Aralez Announces U.S. Commercial Launch Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers 37

Product Approvals 38

Jan 09, 2017: Aralez Submits Marketing Authorization Application To The European Medicines Agency For PA10040 38

Mar 28, 2016: Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA 39

Mar 15, 2016: Aralez resubmits to FDA New Drug Application for YOSPRALA (PA-8140) 40

Other Significant Developments 41

Apr 20, 2016: Aralez Announces Update on YOSPRALA 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42

List of Figures

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

List of Tables

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Aralez Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 9

Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Aralez Pharma Acquires US Rights to Toprol-XL and Authorized Generic from AstraZeneca 11

Aralez Pharma Acquires US and Canadian rights to Zontivity from Merck 12

Aralez Pharma Secures USD75 Million in Venture Debt Financing 13

Biohit Enters Into Distribution Agreement With Medical Futures 14

Cipher Pharma Enters Into Distribution Agreement With Medical Futures 15

Faes Farma Enters into Licensing Agreement with Aralez Pharma 16

Norgine Expands Licensing Agreement With Medical Futures For NORMACOL 16

Apricus Biosciences Enters Into Licensing Agreement with Aralez Pharma 17

Aralez Pharma Raises USD45 Million in Private Placement of Shares 18

Tribute Pharma Acquires Medical Futures for USD20 Million 19

Aralez Pharmaceuticals Inc, Key Competitors 21

Aralez Pharmaceuticals Inc, Key Employees 22

Aralez Pharmaceuticals Inc, Other Locations 23

Aralez Pharmaceuticals Inc, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

select a license

Single User License
USD 250 INR 16263
Site License
USD 500 INR 32525
Corporate User License
USD 750 INR 48788

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com